Thomas Hansen
Norwegian Institute of Public Health
ORCID: 0000-0001-7529-9252Also affiliated with University of Oslo
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 4 papers. Top paper: “SUSTAIN 1: Efficacy and Safety of Once-Weekly Semaglutide Monotherapy vs. Placebo in Subjects with Type 2 Diabetes”.
Shin-Ichi Harashima, George Tsoukas, Jeffrey Unger, Julie Derving Karsbøl, Thomas Hansen +2 more
Mona Bekkhus, Maja Eilertsen, Ragnhild Bang Nes, Monica Beer Prydz, Eivind Ystrøm +58 more
Mona Bekkhus, Maja Eilertsen, Ragnhild Bang Nes, Monica Beer Prydz, Eivind Ystrøm +58 more
Mona Bekkhus, Maja Eilertsen, Ragnhild Bang Nes, Monica Beer Prydz, Eivind Ystrøm +58 more